HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shih-Yi Lin Selected Research

Cholestasis

10/2017Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats.
5/2017Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model.
11/2014Beneficial effect of quercetin on cholestatic liver injury.
8/2014Protective effects of rutin on liver injury induced by biliary obstruction in rats.
3/2012Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
1/2010Stearic acid attenuates cholestasis-induced liver injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shih-Yi Lin Research Topics

Disease

18Inflammation (Inflammations)
07/2022 - 03/2005
15Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2010
14Hyperglycemia
05/2021 - 04/2010
14Insulin Resistance
07/2020 - 01/2003
11Stroke (Strokes)
01/2022 - 01/2011
11Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 11/2005
9Infections
09/2021 - 04/2010
8Fibrosis (Cirrhosis)
07/2022 - 03/2005
8Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 05/2012
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 11/2002
7Ischemic Stroke
12/2021 - 01/2011
7Dementia (Dementias)
06/2021 - 04/2017
7Brain Ischemia (Cerebral Ischemia)
05/2021 - 03/2013
7Neoplasms (Cancer)
02/2021 - 04/2002
7Obesity
06/2020 - 11/2004
7Chronic Kidney Failure (Chronic Renal Failure)
06/2020 - 01/2014
7Weight Loss (Weight Reduction)
10/2016 - 09/2011
6Chronic Renal Insufficiency
01/2022 - 01/2012
6Hypertension (High Blood Pressure)
01/2021 - 09/2005
6Hypoglycemia (Reactive Hypoglycemia)
02/2020 - 11/2002
6Cholestasis
10/2017 - 01/2010
6Body Weight (Weight, Body)
10/2016 - 01/2002
5Diabetes Mellitus
01/2022 - 11/2005
5Glucose Intolerance
12/2021 - 12/2011
5Prediabetic State (Prediabetes)
02/2019 - 08/2015
4Cognitive Dysfunction
01/2022 - 06/2003
4Brain Infarction
12/2021 - 01/2020
4Edema (Dropsy)
12/2021 - 05/2017
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 07/2011
4Thyroid Neoplasms (Thyroid Cancer)
01/2018 - 02/2007
3Liver Diseases (Liver Disease)
07/2022 - 04/2010
3Extrahepatic Cholestasis
07/2022 - 10/2017
3Myocardial Infarction
01/2021 - 11/2002
3Neuroinflammatory Diseases
01/2021 - 05/2020
3Ischemia
12/2020 - 11/2010
3Alzheimer Disease (Alzheimer's Disease)
10/2020 - 04/2017
3Hyperinsulinism (Hyperinsulinemia)
06/2020 - 03/2005
3Albuminuria
01/2019 - 10/2012
3Renal Insufficiency (Renal Failure)
01/2017 - 01/2012
3Diabetic Nephropathies (Diabetic Nephropathy)
02/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

27Glucose (Dextrose)FDA LinkGeneric
12/2021 - 01/2003
14Insulin (Novolin)FDA Link
12/2021 - 01/2002
9Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2010
8Triglycerides (Triacylglycerol)IBA
10/2015 - 09/2005
7Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 05/2012
6CytokinesIBA
10/2017 - 03/2005
5Biological ProductsIBA
07/2022 - 02/2007
5LipidsIBA
01/2022 - 11/2002
5Angiotensin Receptor AntagonistsIBA
12/2021 - 03/2020
5Metformin (Glucophage)FDA LinkGeneric
09/2021 - 09/2011
5C-Reactive ProteinIBA
05/2021 - 11/2002
5Blood Glucose (Blood Sugar)IBA
01/2019 - 04/2010
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2018 - 11/2002
5AcarboseFDA LinkGeneric
03/2017 - 09/2011
5HDL CholesterolIBA
10/2015 - 09/2005
4Caspase 3 (Caspase-3)IBA
07/2022 - 01/2020
4CreatinineIBA
01/2022 - 06/2008
4Hemoglobins (Hemoglobin)IBA
01/2022 - 11/2005
4AlbuminsIBA
01/2022 - 08/2012
4Pharmaceutical PreparationsIBA
12/2021 - 11/2002
4LDL CholesterolIBA
12/2021 - 11/2013
4CorticosteroneIBA
05/2021 - 01/2020
4Air Pollutants (Pollutants, Air)IBA
01/2021 - 11/2019
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2015
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 03/2005
4Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018 - 11/2005
4Glyburide (Glibenclamide)FDA LinkGeneric
03/2017 - 12/2011
4CholesterolIBA
03/2016 - 04/2010
3Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
07/2022 - 02/2016
3Transcription Factors (Transcription Factor)IBA
07/2022 - 01/2021
3HMGB1 Protein (HMG1)IBA
07/2022 - 10/2017
3Transforming Growth Factors (Transforming Growth Factor)IBA
07/2022 - 10/2017
3Nonesterified Fatty Acids (NEFA)IBA
12/2021 - 01/2020
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2021 - 03/2020
3Hormones (Hormone)IBA
09/2021 - 06/2003
3Interleukin-6 (Interleukin 6)IBA
05/2021 - 04/2010
3GasesIBA
01/2021 - 12/2018
3Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 10/2018
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 04/2010
3LeptinIBA
12/2020 - 01/2003
3InterferonsIBA
05/2020 - 01/2017
3Messenger RNA (mRNA)IBA
01/2020 - 04/2014
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 11/2002
3Tyrosine (L-Tyrosine)FDA Link
01/2020 - 03/2013
3Icodextrin (Extraneal)FDA Link
12/2019 - 01/2018
3oxidized low density lipoproteinIBA
11/2018 - 12/2009
3ORALIT (ORS)IBA
01/2018 - 01/2015
3HDL LipoproteinsIBA
01/2015 - 09/2005
3EnzymesIBA
04/2014 - 01/2003
3salicylhydroxamic acid (SHAM)IBA
04/2014 - 03/2005

Therapy/Procedure

18Therapeutics
01/2022 - 01/2002
12Ligation
07/2022 - 03/2005
11Peritoneal Dialysis
01/2022 - 01/2011
8Renal Dialysis (Hemodialysis)
01/2022 - 05/2011
5Glycemic Control
02/2020 - 09/2011
4Aftercare (After-Treatment)
03/2017 - 12/2011
3Oral Administration
05/2022 - 05/2017
3Activities of Daily Living (ADL)
01/2022 - 04/2017
3Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2017 - 01/2014
3Thyroidectomy
01/2009 - 03/2002